Advertisement

Topics

Orion Genomics. Company Profile

07:33 EST 16th December 2018 | BioPortfolio

Orion Genomics develops oncology diagnostic products for cancer screening and therapy selection. We leverage our suite of proprietary technologies to find and interpret normal and abnormal epigenetic patterns of DNA methylation, also known as DNA's Second Code.We are currently identifying epigenetic biomarkers and employing them in the development of novel molecular diagnostic tests to find breast, lung, ovarian, colorectal and other common cancers. Additionally, we are discovering biomarkers that can aid in the selection of best therapies for cancer patients.
Orion Genomics is the Second Code company.

Location

4041 Forest Park Ave
Saint Louis
Missouri
63108
United States of America

Contact

Phone: 314-615-6977
Fax: 314-615-6975
Email: info@oriongenomics.com


News Articles [489 Associated News Articles listed on BioPortfolio]

Orion Corporation: Licenses and Growth for Mid-size Companies in Europe

In this episode of PharmaTelevision News Review, Fintan Walton talks with Jukka Muhonen at Orion Corporation. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss: • Orion's origins a...

M&As this week: Orion Biotechnology Canada, SOPHiA GENETICS, GI Partners

Orion Biotechnology Canada has completed the acquisition of K2Biomedical for an undisclosed sum. K2Biomedical will operate as Orion Biotechnology Poland,...Read More... The post M&As this week: O...

Orion divests Orion Diagnostica division to PE firm Axcel for up to €223mm

An investment fund managed by Nordic private equity investment company Axcel Management AS agreed to acquire Orion Diagnostica Oy (point-of-care testing instruments and kits) for a fixed price of €1...

Bayer, Orion drug shown to delay spread of prostate cancer

German drugmaker Bayer and Finland's Orion said on Wednesday a study showed a prostate cancer drug they are jointly developing can delay the spread of the disease to other parts of the body, boosting ...

MTBC Successfully Closes Orion, Largest Acquisition to Date

Company Acquires Assets of Orion Healthcorp, Inc. and its 13 Affiliates SOMERSET, N.J.,, July 02, 2018 (GLOBE NEWSWIRE) Read more...

Orion Health Selling its Rhapsody Platform for $205 Million

David RathsNew Zealand-based Orion Health Group announced that it will sell its Rhapsody business unit for $205 million to private equity firm Hg. The U.K.-based firm will also take a quarter stake in...

Orion enrols first patient in REFALS trial of levosimendan

Orion has enrolled the first patient in the REFALS trial, a Phase III clinical study of levosimendan (ODM-109) for the...Read More... The post Orion enrols first patient in REFALS trial of levosimenda...

Amgen collaborates with Orion to market Amgevita in Finland

The Orion Group announced on 24 October 2018 that it will distribute Amgen’s adalimumab biosimilar in Finland.

PubMed Articles [208 Associated PubMed Articles listed on BioPortfolio]

Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.

Single-cell genomics.

The Safety and Accuracy of the RHYTHMIA Mapping System in Pediatric Patients.

A new mapping system (Rhythmia) using a 64 mini-electrode small basket array (Orion) was developed and enables rapid high-density mapping in a short time. However, there are few reports about the usef...

Current Social Media Conversations about Genetics and Genomics in Health: A Twitter-Based Analysis.

The growing availability of genomic information to the public may spur discussion about genetics and genomics on social media. Sites, including Twitter, provide a unique space for the public to access...

Lifestyle Genomics: Addressing the Multifactorial Nature of Personalized Health.

Clinical Trials [107 Associated Clinical Trials listed on BioPortfolio]

Early Feasibility Study of the Orion Visual Cortical Prosthesis System

This is an early feasibility study of a new device, the Orion Visual Cortical Prosthesis System. The device is intended to stimulate the surface of the visual cortex to induce visual perce...

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Prospective Registry on User Experience With The Mapping System For Ablation Procedures

This is an observational, prospective, non-randomized, multicenter, post approval study being conducted in the United States, Europe and Asia-Pacific Regions.

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

Companies [435 Associated Companies listed on BioPortfolio]

Orion Genomics.

Orion Genomics develops oncology diagnostic products for cancer screening and therapy selection. We leverage our suite of proprietary technologies to find and interpret normal and abnormal epigenetic ...

Orion Research LLC

Orion Research LLC provides investigative research on public companies and was hired by Pershing Square Capital Management, L.P. to gather information on Herbalife and its Nutriti...

Orion Energy Systems, Inc.

Orion is leading the transformation of commercial and industrial buildings with state-of-the-art energy efficient lighting systems and retrofit lighting solutions. Orion manufactu...

Orion Health, Inc.

Orion Health™ is the leading Health Information Exchange (HIE) solution provider with expertise in clinical workflow and integration technology for the healthcare sector. Ori...

Orion Therapeutics, LLC

Orion Therapeutics is a Troy, Michigan-based biotech company with a mission to discover, develop and commercialize novel products derived from neutraceutical and food supplement m...

More Information about "Orion Genomics." on BioPortfolio

We have published hundreds of Orion Genomics. news stories on BioPortfolio along with dozens of Orion Genomics. Clinical Trials and PubMed Articles about Orion Genomics. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Orion Genomics. Companies in our database. You can also find out about relevant Orion Genomics. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Epigenetics
The development and maintenance of an organism is orchestrated by a set of chemical reactions that switch parts of the genome off and on at strategic times and locations. Epigenetics is the study of these reactions and the factors that influence them. ...


Corporate Database Quicklinks



Searches Linking to this Company Record